当前位置: 首页 > 期刊 > 《中国医学创新》 > 2016年第30期
编号:12942111
Ezrin蛋白在头颈部肿瘤中的研究进展(4)
http://www.100md.com 2016年10月25日 《中国医学创新》 2016年第30期
     [21] Jacobson B C,Hirota W,Baron T H,et al.The role of endoscopy in the assessment and treatment of esophageal cancer[J].Gastrointest Endosc,2013,77(3):817-822.

    [22] Zhai J,Wang Y,Yang F,et al.DRP-1,ezrin and E-cadherin expression and the association with esophageal squamous cell carcinoma[J].Oncol Lett,2014,8(1):133-138.

    [23] Mazzaferri E L,Massoll N.Management of papillary and Follicular(differentiated) thyroid cancer:new paradigms using recombinant human thyrotropin[J].Endcr Related Cancer,2002,9(4):227-247.

    [24] Liu C.The study of the correlation of papillary thyroid carcinoma's invasion toward Ezrin and E-cadherin[J].Journal of Clinical Otorhinolaryngology,Head,and Neck Surgery,2012,26(17):789-791,795.

    [25] Martin-Villar E,Scholl F G,Gamallo C,et al.Characterization of human PA2.26 antigen (T1alpha-2,podoplanin),a small membrane mucin induced in oral squamous cell carcinomas[J].Int J Cancer,2005,113(6):899-910.

    [26]卿菁,张诠,赖非云,等.Ezrin在涎腺腺样囊性癌组织中表达[J].中华肿瘤防治杂志,2007,14(20):1542-1544.

    [27] Madan R,Censler M.Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues:cytoplasmic ezrin expression has prognostic significance for head and neck squamous cell carcinoma[J].Head Neck,2006,28(11):1018-1027.

    (收稿日期:2016-08-05) (本文编辑:李颖), 百拇医药(曹凤祥 戴德)
上一页1 2 3 4